Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss was due to trichotillomania, which is often misdiagnosed and can require different treatments based on age and underlying conditions.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Hair changes can indicate systemic diseases or medication effects.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

A woman with severe hair loss was successfully treated with the drug adalimumab.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Finasteride effectively treats male hair loss, increasing length and thickness.

A hair restoration technique was introduced that mixes different types of hair groupings to reduce procedure time, limit damage, and potentially increase hair density, suggesting more hair can be transplanted than previously thought.

Topical prostaglandin analogs may help with hair growth but more research is needed.

The inhibitor DPP can promote hair growth.

Cosmetics and procedures can cause eye issues, from mild discomfort to serious conditions, due to allergies, toxins, or poor care.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Isotretinoin was not effective in treating facial lichen planopilaris.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Androgens can both increase body hair and cause scalp hair loss.

A boy had unusual synchronized hair growth with short active growth phases, not fitting known hair disorders.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Zidovudine may cause hair loss in advanced-stage HIV patients.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.